Cargando…

Pharmacokinetics of micafungin in patients with severe burn injuries

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Sasaki, J, Kishino, S, Hori, S, Aikawa, N
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066915/ http://dx.doi.org/10.1186/cc9661

Ejemplares similares

Pharmacokinetics of micafungin in patients with severe burn injuries
por: Sasaki, J, et al.
Publicado: (2012)

Micafungin concentrations 100 mg daily in plasma and burn eschars in patients with severe burn injuries
por: Agrifoglio, A, et al.
Publicado: (2015)

Pharmacokinetics of micafungin in adult patients with invasive candidiasis and candidaemia
por: Kuse, ER, et al.
Publicado: (2008)

Pooled analysis of safety for micafungin
por: Cornely, OA, et al.
Publicado: (2008)

Micafungin for the treatment of pediatric invasive fungal infections
por: Arrieta, A, et al.
Publicado: (2009)

Pharmacological modulation with prolonged administration of moderate doses of steroid in a murine model of septic acute lung injury after burn insult
por: Sasaki, J, et al.
Publicado: (2007)

Pharmacokinetics of micafungin in subjects with severe hepatic dysfunction
por: Undre, Nasrullah, et al.
Publicado: (2014)

Outcome following severe burn injuries in Belgium
por: Brusselaers, N, et al.
Publicado: (2006)

Clinical Pharmacokinetics and Pharmacodynamics of Micafungin
por: Wasmann, Roeland E., et al.
Publicado: (2017)

Pharmacokinetics of Micafungin in Critically Ill Patients
por: Gastine, Silke, et al.
Publicado: (2019)

Burn variables and intensive care mortality in severe burn patients
por: Gianesello, L, et al.
Publicado: (2004)

Inhalation injury in critical burn patients
por: Cachafeiro, L, et al.
Publicado: (2013)

Factors associated with mortality in severe burn patients
por: Peñuelas, O, et al.
Publicado: (2006)

Estrogen decreases inflammation and apoptotic signaling in the heart following severe burn injury
por: Gatson, JW, et al.
Publicado: (2010)

Outcome following burns from 1985 to 2004 in the Centre for Severely Burned Patients, Ghent University Hospital, Belgium
por: Brusselaers, N, et al.
Publicado: (2005)

Impact of fluid resuscitation volume on the severity of organ failures in severely burned patients
por: Depaye, N, et al.
Publicado: (2012)

Impact of early catheter removal during treatment of invasive candidiasis: analysis from two phase 3 micafungin trials
por: Nucci, M, et al.
Publicado: (2009)

Effect of low-dose hydrocortisone on gene expression profiles after severe burn injury
por: Plassais, J, et al.
Publicado: (2014)

Ceftazidime dosage regimen recommendations in burn patients based on a Monolix population pharmacokinetic study
por: Ruiz, S, et al.
Publicado: (2012)

Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit Patients
por: Martial, Lisa C., et al.
Publicado: (2017)

Inhalation injury and clinical course in major burned patients
por: Henrich, S, et al.
Publicado: (2014)

1167. Got Micafungin? The Incidence of Fungemia in Patients with Septic Shock
por: Piche, Mackenzie, et al.
Publicado: (2020)

Hospital mortality and length of ICU stay in severely burned patients
por: Meier, S, et al.
Publicado: (2008)

Predictors of mechanical ventilation after burn injury
por: Pirat, A, et al.
Publicado: (2010)

Hemostasis system condition in infectious complication development in severe burned patients
por: Presnyakova, M, et al.
Publicado: (2012)

61. Evaluation of the Impact of a Micafungin Time-Out Protocol for Hospitalized Patients
por: Williams, Kelsey N, et al.
Publicado: (2020)

Hemostasis system condition in progress of sepsis in severe burns
por: Presnyakova, M, et al.
Publicado: (2011)

Efficacy of antithrombin administration in the acute phase of burn injury
por: Lavrentieva, A, et al.
Publicado: (2008)

Lactate in the burn patient
por: Herrero, EH, et al.
Publicado: (2015)

Pharmacokinetics of micafungin in patients treated with extracorporeal membrane oxygenation: an observational prospective study
por: López-Sánchez, Marta, et al.
Publicado: (2020)

Biomarkers of sepsis in burn patients
por: Oueslati, H, et al.
Publicado: (2010)

Apoptosis of neutrophils, expression of TREM-1 on neutrophils and IL-17 responses in experimental burn in injury are related to the type and time of burn exposure
por: Alexis, A, et al.
Publicado: (2012)

Comparison of bacterial isolated from burn wounds in ICU and burn ward patients
por: Mano, V, et al.
Publicado: (2011)

1319. Pharmacokinetics of Ceftolozane/Tazobactam in Patients with Burns
por: Hall, Ronald G, et al.
Publicado: (2020)

Intraabdominal hypertension in burn patients
por: Mokline, A, et al.
Publicado: (2015)

Validation of inflationary non-invasive blood pressure monitoring in emergency room patients
por: Sasaki, J, et al.
Publicado: (2014)

594. Micafungin Prophylaxis in Acute Myeloid Leukemia Adult Patients Undergoing Induction Chemotherapy
por: Ross, Justine Abella, et al.
Publicado: (2021)

Assessment of acute kidney injury with modified RIFLE criteria in critically ill pediatric burn patients
por: Palmieri, T, et al.
Publicado: (2009)

Increased risk of ischemic stroke in patients with burn injury: a nationwide cohort study in Taiwan
por: Hung, TY, et al.
Publicado: (2015)

Safety, pharmacokinetics, and pharmacodynamics of 4-hour intravenous infusion of eritoran tetrasodium in healthy Japanese and Caucasian males
por: Okubo, Y, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_seldg58pcs78opkj9dkg0ag720